Ingalls & Snyder »

Supernus Pharmaceuticals shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2023-12-31 $657k 23k 28.96
2023-09-30 $681k 25k 27.58
2023-06-30 $1.1M 36k 30.07
2023-03-31 $1.3M 36k 36.23
2022-12-31 $1.4M 40k 35.68
2022-09-30 $1.4M 40k 33.84
2022-06-30 $1.2M 40k 28.91
2022-03-31 $1.3M 40k 32.32
2021-12-31 $1.2M 40k 29.16
2021-09-30 $1.9M 70k 26.68
2021-06-30 $2.2M 72k 30.79
2021-03-31 $1.9M 72k 26.17
2020-12-31 $1.8M 72k 25.16
2020-09-30 $1.5M 71k 20.84
2020-06-30 $1.7M 71k 23.75
2020-03-31 $1.3M 71k 17.99
2019-12-31 $1.7M 71k 23.72
2019-09-30 $4.8M 175k 27.48
2019-06-30 $5.5M 165k 33.09
2019-03-31 $6.0M 171k 35.04
2018-12-31 $5.7M 171k 33.22
2018-09-30 $8.6M 171k 50.35
2018-06-30 $10M 171k 59.85
2018-03-31 $7.9M 174k 45.80
2017-12-31 $7.0M 176k 39.85
2017-09-30 $7.0M 176k 40.00
2017-06-30 $7.6M 176k 43.10
2017-03-31 $5.7M 181k 31.30
2016-12-31 $4.8M 191k 25.25
2016-09-30 $4.8M 193k 24.73
2016-06-30 $3.9M 193k 20.37